Participant flow14

How many started, completed or left each group, period by period.

1 to 14 of 14

Period	Milestone	Group	Participants
Overall Study	STARTED	Gepotidacin	805
Overall Study	STARTED	Nitrofurantoin	800
Overall Study	Safety Population	Gepotidacin	804
Overall Study	Safety Population	Nitrofurantoin	798
Overall Study	Microbiological ITT (Micro ITT) Population	Gepotidacin	331
Overall Study	Microbiological ITT (Micro ITT) Population	Nitrofurantoin	324
Overall Study	Micro-ITT NTF-S Population	Gepotidacin	292
Overall Study	Micro-ITT NTF-S Population	Nitrofurantoin	275
Overall Study	Micro-ITT NTF-S (IA Set) Population	Gepotidacin	277
Overall Study	Micro-ITT NTF-S (IA Set) Population	Nitrofurantoin	264
Overall Study	COMPLETED	Gepotidacin	748
Overall Study	COMPLETED	Nitrofurantoin	759
Overall Study	NOT COMPLETED	Gepotidacin	57
Overall Study	NOT COMPLETED	Nitrofurantoin	41

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04187144/flow